Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Wuhan Humanwell Healthcare (Group) Co Ltd to Acquire Equity Shares


Monday, 18 Feb 2013 07:00pm EST 

Wuhan Humanwell Healthcare (Group) Co Ltd announced that it will acquire a 15% stake in a Wuhan-based biological products company from Mr. Fan Shaowen at RMB 52.50 million. The target company is engaged in the biological products, blood products, manufacturing and sales. After that, the Company will hold a 100% stake in the target company. 

Company Quote

26.66
-0.23 -0.86%
23 Apr 2014